CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review
20260 citationsJournal Article
Field-Weighted Citation Impact: 0.00
CRE26-049: Intrathecal Rituximab for Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Case Report and Literature Review | Researchclopedia